21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
Nutritional supplement for use under physiologically stressful conditions
#8702Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications
#8703CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE
#8704Modified vaccinia virus ankara for the vaccination of neonates
#8705Human antibodies to human angiopoietin-like protein 4
#870611-β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors and uses thereof
#8707COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES
#8708ANG-2 INHIBITION TO TREAT MULTIPLE SCLEROSIS
#8709Enzymes for pharmaceutical use
#8710USE OF BLOOD GROUP STATUS I
#8711Metabolically active micro organisms and methods for their production
#8712Treatment Using Herpes Simplex Virus
#8713SYNERGISTIC STIMULATION OF THE IMMUNE SYSTEM USING IMMUNOSTIMULATORY OLIGONUCLEOTIDES AND/OR IMMUNOMER COMPOUNDS IN CONJUNCTION WITH CYTOKINES AND/OR CHEMOTHERAPEUTIC AGENTS OR RADIATION THERAPY
#8714Use of interleukin 17E for the treatment of cancer
#8715PHOTO-PROTECTIVE DERMATOLOGICAL FORMULATIONS
#8716Method and system using relays with aggregated spectrum
#8717CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTICS DELIVERY
#8718ANHYDROUS PETROLEUM JELLY/ELASTOMER-FREE DEPIGMENTING COMPOSITIONS COMPRISING A SOLUBILIZED PHENOLIC COMPOUND AND A RETINOID
#8719METHODS OF TREATING EPILEPTOGENESIS AND EPILEPSY
#8720Fluorescent regulators of RASSF1A expression and human cancer cell proliferation
#8721COMBINATION THERAPY WITH PARP INHIBITORS
#8722Combination Therapy For Glaucoma
#8723Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions
#8724Antiparisitic dihydroazole compounds and compositions comprising same
#8725Chemical Compounds
#8726Novel dicyclanil-based shelf stable aqueous suspension and non-aqueous solution pour-on and spray-on formulations useful for the prevention and treatment of insect infestation in animals
#8727Methods of treating vasomotor symptoms
#8728Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use
#8729AGENT FOR MAINTENANCE OF INDUCED REMISSION
#8730Preparations and methods for ameliorating or reducing presbyopia
#8731SHIGA TOXIN B-SUBUNIT/CHEMOTHERAPEUTICS CONJUGATES
#8732METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS
#8733THERAPEUTIC AGENT FOR ANCA-RELATED VASCULITIS
#8734Methods of treating bone mass diseases
#8735USE OF VITAMIN D GLYCOSIDES AND SULFATES FOR TREATMENT OF DISEASE
#8736Therapeutic combinations for use in neoplasia
#8737Pharmaceutical compositions containing botulinum toxin
#8738Smoking Cessation Lozenge Containing Tobacco Alkaloid And Silver Salt
#8739Topical anti-inflammatory combination
#8740Compositions for alleviating inflammation and oxidative stress in a mammal
#8741Compositions and Methods for Preventing Migraines
#8742COMBINATION THERAPY WITH PARP INHIBITORS
#8743Nutritional supplement for use under physiologically stressful conditions
#8744ACTIVE SUBSTANCE COMBINATION WITH GEMCITABINE FOR THE TREATMENT OF EPITHELIAL CANCER
#8745OPHTHALMIC SOLUTIONS WITH IMPROVED DISINFECTION PROFILES
#8746Use of angiogenin or angiogenin agonists for treating diseases and disorders
#8747COMPOSITIONS COMPRISING POORLY WATER SOLUBLE PHARMACEUTICAL AGENTS AND ANTIMICROBIAL AGENTS
#8748Use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
#8749Methods and means for soft tissue engineering
#8750Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
#8751Dissolvable dietary supplement strip and methods for using the same
#8752Chlorhexidine acetate antiseptic cleaning agent
#8753METHODS AND MATERIALS FOR GASTROINTESTINAL DELIVERY OF PATHOGEN/TOXIN BINDING AGENTS
#8754Binding member which binds to both lewis-Y and lewis-B haptens, and its use for treating cancer
#8755TREATING CANCER
#8756Anti-hepcidin antibodies and methods of use
#8757Anti-AREG/HB-EGF antibodies and treatment
#8758AMINOACYL TRNA SYNTHETASES FOR MODULATING HEMATOPOIESIS
#8759COMPOSITIONS AND METHODS FOR MANIPULATING LEVELS OF ANTIGEN-SPECIFIC ANTIBODIES IN A MAMMAL
#8760Method of reducing total cholesterol level by administering matrilin-2 polypeptide
#8761ANTI-INFLAMMATORY COMPOSITIONS AND COMBINATIONS
#8762Macrocyclic Inhibitors of Hepatitis C Virus NS3 Serine Protease
#8763Furin-knockdown bi-functional RNA
#8764Nutritional Composition for Improving the Mammalian Immune System
#8765COMBINATION THERAPY FOR COPD
#8766AEROSOL FORMULATION FOR COPD
#8767COMBINATION THERAPY FOR COPD
#8768Transdermal patch with fatal overdose protection
#8769Frozen compositions and methods for piercing a substrate
#8770PRLR-specific antibody and uses thereof
#8771Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof
#8772INTRAUTERINE DELIVERY SYSTEM FOR CONTRACEPTION
#8773AEROSOL FORMULATION FOR COPD
#8774PHARMACEUTICAL COMPOSITIONS AND METHODS OF DELIVERING THE SAME
#8775Process For Producing Porous Scaffolds From Sinterable Glass
#8776Bruise amelioration composition and method of use
#8777USE OF VASOCONSTRICTORS
#8778COMBINATION OF CAROTENOIDS AND EPI-LUTEIN
#8779Pharmaceutical Composition Comprising Cinchonains Ia And Ib, Process For Preparing An Epimeric Mixture Of Cinchonains Ia And Ib, Use And Method For Reverting/Combating Ventricular Fibrillation
#8780Oxotetrahydrofuran-2-yl-benzimidazole derivative
#8781METHODS FOR TREATING VISCERAL FAT CONDITIONS
#8782IBUPROFEN AND NARCOTIC ANALGESIC COMPOSITIONS
#8783Pharmaceutical composition containing ferulic acid and matrine compounds, the preparation and the use thereof
#87845-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts
#8785Method of treating organophosphorous poisoning
#8786Inhibitors of the plasmodial surface anion channel as antimalarials
#8787COMPOUNDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES
#8788Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
#8789Health Care
#8790Niacin prodrugs and deuterated versions thereof
#8791Compositions and methods for treatment of mitochondrial diseases
#8792Salts of HIV inhibitor compounds
#8793ANTHELMINTIC COMPOSITIONS
#8794USE OF FUMAGILLIN AND THE DERIVATIVES THEREOF TO INCREASE THE BIOAVAILABILITY OF THE MACROCYCLIC LACTONES
#8795Composition and method for increasing post workout recovery
#8796Methods and Compositions for Treating Conditions of the Eye
#8797METHOD OF TREATING CHRONIC HEART FAILURE
#8798PROTEIN COMPOSITION
#8799Maintenance therapy regime/regimen for the treatment of acne
#8800Specialized dial a chip
#8801ANTI-VEGF-C ANTIBODIES AND METHODS USING SAME
#8802Polyphenol-containing products
#8803USE OF AN ONION EXTRACT FOR MAKING A COMPOSITION TO CONTROL WEIGHT GAIN
#8804Nutritional supplement
#8805Method of reducing blood cholesterol and triglyceride levels using combinations of vasoprotective agent
#8806Herbal medicinal composition and extract thereof for inhibiting growth of cancer cells
#8807NUTRITIONAL SUPPLEMENT FOR OSTEOARTHRITIS
#8808Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders
#8809TOPICAL TREATMENT AND MANUFACTURING METHOD
#8810Combinations of immunosuppressive agents for the treatment or prevention of graft rejections
#8811Use of a Combination of an Opioid Agonist and an Opioid Antagonist for the Treatment of Crohn's Disease and the Symptoms Associated with Crohn's Disease
#8812OPHTHALMIC PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEOANGIOGENIC PATHOLOGIES OF THE EYE
#8813STABILIZED COMPOSITION AND METHOD FOR DERMATOLOGICAL TREATMENT
#8814Cytotoxic T-Lymphocyte-Inducing Immunogens for Prevention, Treatment and Diagnosis of Cancer
#8815Composition and method for treating atherosclerosis, method for determining if a subject has atherosclerosis and method of screening an anti-atherosclerotic drug
#8816Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication
#8817Hypoxia Inducing Factor (HIF) Stabilising Glasses
#8818ANTI-BETA-2-MICROGLOBULIN AGENTS AND THE USE THEREOF
#8819Method Of Treating Acute Respiratory Distress Syndrome
#8820METHODS FOR TREATING AND PREVENTING FIBROSIS
#8821Soluble tumor necrosis factor receptor treatment of medical disorders
#8822Modulation of the TrpV: Vps10p receptor system for the treatment of pain
#8823ANTI-TUMOUR COMPOSITIONS AND METHODS
#8824TREATMENT OF CANCER WITH A COMBINATION OF AN AGENT THAT PERTURBS THE EGF SIGNALING PATHWAY AND AN OLIGONUCLEOTIDE THAT REDUCES CLUSTERIN LEVELS
#8825Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases
#8826Thermostabilization of proteins
#8827Compounds, composition, methods, targets for cancer therapy
#8828Suppressive macrophages, C-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic
#8829MEASLES VIRUS FOR THE ELIMINATION OF UNWANTED CELL POPULATIONS
#8830Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
#8831METHODS OF TREATING COGNITIVE IMPAIRMENT
#8832Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy
#8833COMPOSITION FOR TREATING ARTICULAR CARTILAGE DEFECT, AND METHOD OF MANUFACTURE THEREOF
#8834Composition and periodical delivery system for cellular rejuvenation
#8835TREATMENT OF OBESITY
#8836KIT OF TAMPONING LIQUIDS AND A METHOD FOR THE TREATMENT OF TEARS AND/OR DETACHMENTS OF THE RETINA USING SUCH LIQUIDS
#8837Bruise amelioration composition and method of use
#8838COMBINATION OF DRONEDARONE WITH AT LEAST ONE DIURETIC, AND THERAPEUTIC USE THEREOF
#8839TOLL-LIKE RECEPTOR 9 AGONISTS FOR THE TREATMENT OF ANXIETY-RELATED DISORDERS AND INFLAMMATORY DISORDERS
#8840Targeting TGF-β as a therapy for Alzheimer's disease
#8841Synergistic combination of analgesic compounds
#8842Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
#8843Preferred Combination Therapy
#8844Morphinan derivatives for the treatment of drug overdose
#8845(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
#8846Combination of two analgesic chemicals
#8847Methods for Altering MRNA Splicing and Treating Familial Dysautonomia and Other Mechanistically Related Disorders
#8848COMBINATION FORMULATIONS OF TRANILAST AND ALLOPURINOL AND METHODS RELATED THERETO
#8849COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS
#8850Therapeutic compositions containing macitentan
#8851Antitumor agent, kit and method of treating cancer
#8852Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
#8853COMBINATION OF A NICOTINIC RECEPTOR PARTIAL AGONIST AND OF AN ACETYLCHOLINESTERASE INHIBITOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND USE THEREOF IN THE TREATMENT OF COGNITIVE DISORDERS
#8854Copper(1)Chloride Complex of Nicotinic Acid and Pharmaceutical Compositions Containing the Same
#8855Methods for treating injury associated with exposure to an alkylating species
#8856Processes for preparing piperazinium salts of KMUP and use thereof
#8857Trisubstituted boron-containing molecules
#8858Combination antitumor therapy
#88592-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY
#8860Use of Polyphenols in the Treatment of Cancer
#8861Use of S1P Receptor Agonists in Heart Diseases
#8862Methods of modulating inflammation in preterm infants using carotenoids
#8863NOVEL ANTIMICROBIAL AGENTS
#8864Use of methylsulfonylmethane (MSM) to modulate microbial activity
#8865Ayurvedic formulation advocated for the prevention and management of coronary heart disease
#8866DIHYDRO-ISOALPHA ACID AND ACACIA NILOTICA EXTRACT BASED COMPOSITIONS AND METHODS FOR WEIGHT MANAGEMENT
#8867Synergistic antioxidant combinations of herb extracts and methods relating thereto
#8868Synergistic antioxidant combinations of herb extracts and methods relating thereto
#8869Antiseptic formulation especially for prevention of complications associated with skin burns
#8870Stem cell/endothelial progenitor cell mobilization by nutraceutical formulations
#8871Laxative and process for making same
#8872COMPOSITIONS AND METHODS FOR PROTECTING SENSORY HAIR CELLS
#8873Combination therapies for treating neoplastic disease
#8874Nutritional Supplement For Patients With Chronic Heart Failure
#8875ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM
#8876USE OF A TRADITIONAL CHINESE MEDICINAL COMPOSITION FOR PREPARING MEDICINE FOR PROMOTING BONE MARROW-DERIVED MESENCHYMAL STEM CELL SURVIVAL IN VIVO AND DIFFERENTIATION INTO CARDIOMYOCYTES
#8877Protective lip balm composition
#8878COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS
#8879Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent
#8880ABUSE-RESISTANT OPIOID DOSAGE FORM
#8881GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR EXTENDED RELEASE OF POLYPEPTIDES
#8882PHARMACEUTICAL FORMULATION COMPRISING A PROTON PUMP INHIBITOR AND ANTACIDS
#8883Preparations with rosehip extracts, and method of producing rosehip extracts
#8884Polymer coatings containing phytochemical agents and methods for making and using same
#8885PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD AND USES THEREOF
#8886COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES
#8887DIETARY SUPPLEMENT - LIQUID FILLED GUM
#8888Multilayered blood product
#8889Immunomodulation by IAP inhibitors
#8890Composition and Method for Enhancing Insulin Activity
#8891Methods for treating reperfusion injuries using flagellin
#8892METHOD AND COMPOSITION FOR ENHANCING HEMATOPOIETIC STEM CELL MOBILIZATION
#8893Morpholinone compounds as factor IXA inhibitors
#8894Methods and compositions for enhanced delivery of macromolecules
#8895TRIMODAL CANCER THERAPY
#8896Recombinant anti-epidermal growth factor receptor antibody compositions
#8897METHODS OF INHIBITING INFECTION BY DIVERSE SUBTYPES OF DRUG-RESISTANT HIV-1
#8898Inhibition of macrophage-stimulating protein receptor (RON) and methods of treatment thereof
#8899PAIN RELIEF COMPOSITION, SYSTEM AND METHOD
#8900INHIBITING BACTERIAL INFECTION AND BIOFILM FORMATION
#8901Medicinal product for treating gastrointestinal ulcers
#8902METHODS FOR TREATING APOLIPOPROTEIN E4-ASSOCIATED DISORDERS
#8903USE OF PROBIOTIC BACTERIA FOR THE TREATMENT OF HYPERHOMOCYSTEINAEMIA
#8904METHODS AND PRODUCTS RELATED TO TREATMENT AND PREVENTION OF HEPATITIS C VIRUS INFECTION
#8905Neuregulin based methods and compositions for treating cardiovascular disease
#8906Pharmaceutical/cosmetic, E.G., anti-acne compositions comprising at least one naphthoic acid compound, benzoyl peroxide and at least one film-forming agent
#8907COMBINATION OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#8908Novel Medicament Combinations for the Treatment of Respiratory Diseases
#8909HYBRID NANOPARTICLES AS ANTI-CANCER THERAPEUTIC AGENTS AND DUAL THERAPEUTIC/IMAGING CONTRAST AGENTS
#8910COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
#8911Compositions for pulmonary delivery of long-acting βadrenergic receptor agonists and associated methods and systems
#8912TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH NEBULIZED BETA 2-AGONIST OR COMBINED NEBULIZED BETA 2-AGONIST AND ANTICHOLINERGIC ADMINISTRATION
#8913Reduced-odor thiol compositions
#8914Treatment of obesity and related disorders
#8915THERAPY FOR VITILIGO
#8916INCREASED CREATINE RETENTION WITH SOLUBLE FIBRES
#8917Nitrate esters and their use for the treatment of muscle and muscle related diseases
#8918Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof
#8919Use of COX-2 Inhibitors for the Treatment of Schizophrenia, Delusional Disorders, Affective Disorders, Autism or Tic Disorders
#8920Small Pyrimidine Derivatives and Methods of Use Thereof
#8921Methods for administration and formulations for the treatment of regional adipose tissue
#8922COMPOSITION COMPRISING ESTRONE AND HYDROCORTISONE FOR USE IN THE TOPICAL TREATMENT OF BALDNESS
#8923Pharmaceutical composition comprising a strontium salt, vitamin D and A cyclodextrin
#8924Combination Therapy for Treating Proliferative Diseases
#8925Methods for preventing or reducing neurotoxicity associated with administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs
#8926Morphine and morphine precursors
#8927Methods for treatment of reperfusion injury and other cardiac conditions
#8928Therapeutic combination comprising a pulmonary surfactant and a steroid
#8929Apoptosis-modulating p53 protein therapy for vascular disorders and nanoparticles containing the same
#8930Method of making an artificial micro-gland using taxis
#8931Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions
#89322′-branched nucleosides and mutation
#8933Soy Protein-Based Nutritional Formula with Superior Stability
#8934Acne Treatment
#8935CANCER TREATMENT METHOD
#8936Immunopotentiating Compositions Comprising Beta-1, 3/1, 6-D-Glucan and Uses Thereof
#8937DERMATOLOGICAL PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN INFLAMMATION DISEASES, SUCH AS DERMATITIS, ATOPIC DERMATITIS, VITILIGO, ALOPECIA AREATA, ACNE, PSORIASIS, PRURITUS OR COMBINATIONS OF SAME
#8938Fermented plant extracts, methods of production and uses
#8939METHOD AND MEANS FOR TREATING VIRAL DISEASE, IN PARTICULAR HIV/AIDS
#8940Dermal fillers comprising silk fibroin hydrogels and uses thereof
#8941Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture
#8942COMPOSITIONS AND METHODS FOR TREATING VASCULAR DISEASE
#8943Therapeutic agent for cancer, and method for treatment of cancer
#8944Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, prepartion, for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
#8945Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
#8946METHODS AND COMPOSITIONS FOR THE MANAGEMENT OF PAIN USING OMEGA-CONOTOXINS
#8947CONTROLLED RELEASE FORMULATIONS EXHIBITING AN ASCENDING RATE OF RELEASE
#8948Tumor vaccination in combination with hematopoietic cell transplantation for cancer therapy
#8949Use of mTOR inhibitors to enhance T cell immune responses
#8950METHODS FOR TREATING FATTY LIVER DISEASE
#8951THERAPEUTIC COMBINATION COMPRISING AN AURORA KINASE INHIBITOR AND ANTIPROLIFERATIVE AGENTS
#8952HUMANIZED ANTI-ERBB2 ANTIBODIES AND TREATMENT WITH ANTI-ERBB2 ANTIBODIES
#8953Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof
#8954Sequential Administration of Chemotherapeutic Agents for Treatment of Cancer
#8955Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions
#8956Method for decreasing borborygmi by administering a bifidobacterium bacteria
#8957METHODS TO MOBILIZE PROGENITOR/STEM CELLS
#8958Combinations comprising methotrexate and DHODH inhibitors
#8959Conditioned medium of liver progenitor cells
#8960Compositions and Methods for Treating or Preventing Gastrointestinal Disorders and GERD-Related Respiratory Disorders
#8961Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia
#8962Light activated composite tissue adhesives
#8963N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION
#8964ORAL PHARMACEUTICAL SUSPENSION COMPRISING PARACETAMOL AND IBUPROFEN
#8965Treatment for meibomian gland dysfunction or obstruction
#8966Compounds for Preventing and Treating Plasmodium Infections
#8967COMPOSITIONS AND METHODS FOR TREATING CANCER OR A NEUROTROPHIC DISORDER
#8968Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fibrosis
#8969Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
#8970Benzimidazoles and related analogs as sirtuin modulators
#8971TREATMENT OF COGNITIVE DISORDERS WITH CERTAIN ALPHA-7 NICOTINIC ACID RECEPTORS IN COMBINATION WITH ACETYLCHOLINESTERASE INHIBITORS
#8972Combination Therapy for BreastCancer Comprising an Antiestrogenic Agent
#8973Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
#8974Method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin K
#8975Methods for determining chemotherapeutic agents targeting alpha-glucan pathways and uses thereof
#8976INHALED FOSFOMYCIN/TOBRAMYCIN FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#8977PREPARATION FOR ORAL ADMINISTRATION COMPRISES QUERCETIN GLYCOSIDE AND A WATER-BASED SOLVENT EXTRACT OF CARTILAGE CONTAINING CHONDROITIN SULFATE
#8978Apoaequorin-containing compositions and methods of using same
#8979Insulin-oligomer conjugates, formulations and uses thereof
#8980THYMOSIN BETA 4 PROMOTES WOUND REPAIR
#8981Inducing cell death by inhibiting adaptive heat shock response
#8982SYNERGISTIC ENHANCEMENT OF CELLULAR ERGOGENIC NUTRIENT UPTAKE, LIKE CREATINE OR CARNITINE, WITH TARRAGON
#8983COMPOSITIONS AND METHODS FOR OPTIMIZING EXERCISE RECOVERY
#8984HERBAL EXTRACT COMPOSITION
#8985NOVEL FERMENTED MILK PRODUCT AND USE THEREOF
#8986Compound for improving brain functioning and/or treatment of brain disorders
#8987Formulations comprising aminosterols
#8988PHARMACEUTICAL PREPARATION CONTAINING NON-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-2 RECEPTOR BLOCKER
#8989MULTIPLE UNIT DOSAGE FORM OF NIACIN
#8990Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering
#8991INTESTINAL ENVIRONMENT-IMPROVING AGENT
#8992Methods and compositions for treating phenylketonuria
#8993Compositions Comprising Antibodies or Antibody Fragments
#8994COMBINATION OF VEGFR2 AND IGF1R INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES
#8995TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease
#8996Methods for treating hematopoietic malignancies
#8997Antibodies against ERBB3 and uses thereof
#8998Methods of treating cancer using anti CD24 antibodies
#8999Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
#9000DISSOLVABLE PHARMACEUTICAL IMPLANT